Filing Flows

Filing Flows › Companies › Astera Labs › Timeline

Astera Labs stock timeline

A year of the price with every insider trade, planned sale, earnings report and material 8-K marked

252 sessions+17.1% to $190.71

Astera Labs (ALAB) stock rose 17% over the last 252 sessions, to $190.71. On the way it reported 4 quarters, its insiders filed 3 open-market trades and 12 Form 144 notices of planned sales, and the company filed 4 material 8-Ks. Each is marked on the price and listed with what the stock did next.

ALAB: a year of the stock with every disclosure on itALAB: a year of the stock with every disclosure on it$181$292$403$514◆2026-01-20 · Directors and officers: departures, appointments, pay●2026-02-10 · Earnings: beat the EPS estimate by 12.6%◆2026-02-10 · Directors and officers: departures, appointments, pay◆2026-02-10 · Material definitive agreement●2026-05-05 · Earnings: beat the EPS estimate by 13.5%▽2026-06-24 · Form 144: Bethany Mayer plans to sell $276K▽2026-07-01 · Form 144: Stefan Dyckerhoff plans to sell $5.6M▽2026-07-01 · Form 144: Mar 2011 Childrens Trust U/A DTD 06/01/2011 plans to sell $82.1M▽2026-07-01 · Form 144: Casa Alameda 2007, LLC plans to sell $15.9M▽2026-07-01 · Form 144: Alba 2003 Living Trust plans to sell $72.5M●2026-08-04 · Earnings: beat the EPS estimate by 15.6%▽2026-08-06 · Form 144: Stefan A Dyckerhoff plans to sell $3.9M▼2026-08-17 · Gajendra Sanjay sold $30.8M▼2026-08-17 · Mazzara Philip sold $2.3M▼2026-08-17 · Mohan Jitendra sold $30.8M▽2026-09-01 · Form 144: Mar 2011 Childrens Trust plans to sell $50.5M▽2026-09-01 · Form 144: Alba 2003 Living Trust plans to sell $44.5M▽2026-09-01 · Form 144: Casa Alameda 2007, LLC plans to sell $9.8M▽2026-09-02 · Form 144: Stefan Dyckerhoff plans to sell $3.4M▽2026-10-07 · Form 144: Stefan A Dyckerhoff plans to sell $4.7M●2026-11-03 · Earnings: beat the EPS estimate by 10.7%◆2026-11-04 · Directors and officers: departures, appointments, pay▽2026-11-05 · Form 144: Stefan A Dyckerhoff plans to sell $37.4M◆8-K event●Earnings report▽Planned sale (Form 144)▼Insider sale2025-11-062026-11-06
Daily closes, Nov 6, 2025 to Nov 6, 2026; hover a mark for the filing.

Each mark, and what followed

DateKindWhatNext session5 sessions21 sessions
Nov 5, 2026Form 144Form 144: Stefan A Dyckerhoff plans to sell $37.4M−21.8% (−17.3% vs SPY)——
Nov 4, 20268-KDirectors and officers: departures, appointments, pay−21.8% (−17.3% vs SPY)——
Nov 3, 2026EarningsEarnings: beat the EPS estimate by 10.7%+1.7% (+1.4% vs SPY)——
Oct 7, 2026Form 144Form 144: Stefan A Dyckerhoff plans to sell $4.7M−2.0% (−1.7% vs SPY)−18.1% (−17.9% vs SPY)−55.7% (−54.1% vs SPY)
Sep 2, 2026Form 144Form 144: Stefan Dyckerhoff plans to sell $3.4M−2.1% (−2.5% vs SPY)+7.1% (+7.0% vs SPY)+24.2% (+23.6% vs SPY)
Sep 1, 2026Form 144Form 144: Casa Alameda 2007, LLC plans to sell $9.8M−5.9% (−5.2% vs SPY)−2.8% (−2.6% vs SPY)+18.1% (+18.4% vs SPY)
Sep 1, 2026Form 144Form 144: Alba 2003 Living Trust plans to sell $44.5M−5.9% (−5.2% vs SPY)−2.8% (−2.6% vs SPY)+18.1% (+18.4% vs SPY)
Sep 1, 2026Form 144Form 144: Mar 2011 Childrens Trust plans to sell $50.5M−5.9% (−5.2% vs SPY)−2.8% (−2.6% vs SPY)+18.1% (+18.4% vs SPY)
Aug 17, 2026Insider saleMohan Jitendra sold $30.8M−0.4% (0.0% vs SPY)−12.1% (−10.7% vs SPY)−24.2% (−21.7% vs SPY)
Aug 17, 2026Insider saleMazzara Philip sold $2.3M−0.4% (0.0% vs SPY)−12.1% (−10.7% vs SPY)−24.2% (−21.7% vs SPY)
Aug 17, 2026Insider saleGajendra Sanjay sold $30.8M−0.4% (0.0% vs SPY)−12.1% (−10.7% vs SPY)−24.2% (−21.7% vs SPY)
Aug 6, 2026Form 144Form 144: Stefan A Dyckerhoff plans to sell $3.9M+4.0% (+4.2% vs SPY)+0.1% (−0.2% vs SPY)−11.9% (−12.3% vs SPY)
Aug 4, 2026EarningsEarnings: beat the EPS estimate by 15.6%+11.9% (+10.1% vs SPY)−1.2% (−3.2% vs SPY)−13.7% (−14.3% vs SPY)
Jul 1, 2026Form 144Form 144: Alba 2003 Living Trust plans to sell $72.5M−11.4% (−11.3% vs SPY)−20.6% (−20.4% vs SPY)−47.7% (−47.1% vs SPY)
Jul 1, 2026Form 144Form 144: Casa Alameda 2007, LLC plans to sell $15.9M−11.4% (−11.3% vs SPY)−20.6% (−20.4% vs SPY)−47.7% (−47.1% vs SPY)
Jul 1, 2026Form 144Form 144: Mar 2011 Childrens Trust U/A DTD 06/01/2011 plans to sell $82.1M−11.4% (−11.3% vs SPY)−20.6% (−20.4% vs SPY)−47.7% (−47.1% vs SPY)
Jul 1, 2026Form 144Form 144: Stefan Dyckerhoff plans to sell $5.6M−11.4% (−11.3% vs SPY)−20.6% (−20.4% vs SPY)−47.7% (−47.1% vs SPY)
Jun 24, 2026Form 144Form 144: Bethany Mayer plans to sell $276K+0.7% (+0.8% vs SPY)+19.6% (+17.8% vs SPY)−19.4% (−20.0% vs SPY)
May 5, 2026EarningsEarnings: beat the EPS estimate by 13.5%+6.9% (+6.1% vs SPY)+3.0% (+0.1% vs SPY)+59.1% (+54.2% vs SPY)
Feb 10, 20268-KMaterial definitive agreement−24.1% (−24.1% vs SPY)−34.4% (−33.6% vs SPY)−42.2% (−38.3% vs SPY)
Feb 10, 20268-KDirectors and officers: departures, appointments, pay−24.1% (−24.1% vs SPY)−34.4% (−33.6% vs SPY)−42.2% (−38.3% vs SPY)
Feb 10, 2026EarningsEarnings: beat the EPS estimate by 12.6%−2.6% (−2.3% vs SPY)−41.7% (−40.1% vs SPY)−40.9% (−38.3% vs SPY)
Jan 20, 20268-KDirectors and officers: departures, appointments, pay−4.3% (−5.5% vs SPY)−7.2% (−9.8% vs SPY)−32.6% (−33.6% vs SPY)

Insiders’ record here

In the year on the chart, Astera Labs' insiders reported 0 open-market buys ($0) and 3 sales ($64.0M).

Across the whole universe (19,782 scored trades), insider buys beat the market 46% of the time and sales were followed by a lagging stock 61% of the time; buys of $1M or more 39%. Every pattern →

What this kind of 8-K usually did

Item8-KsNext session, medianUp next session21 sessions, medianTypical size
5.02 Directors and officers: departures, appointments, pay39,174−0.1%48%+0.7%±1.4%
1.01 Material definitive agreement23,5250.0%51%+1.0%±1.4%

Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →

Report card: every quarter against the estimate → Astera Labs: every quarter → Live insider trades →

Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.